Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic variability of opioid substitution dose requirements
2008-002714-22Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methadone, buprenorphine, naloxone and morphine in opioid use disorder (OUD) (4 cohorts), sponsored by Medical University of Innsbruck. Started Jul 2008; status: completed.
02
Drugs
methadonebuprenorphinenaloxonemorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2008-002714-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002714-22.